CitraFlow™ 46.7% SF for Vascular Access Device locking

MedXL

SKU Select options
(No reviews yet) Write a Review
$1,550.00 - $1,844.44
View full description ↓
  • Healthcare-grade equipment
  • Canada-wide shipping
  • B2B & bulk pricing available
Adding to cart… The item has been added
Secure checkout with:
Visa Mastercard American Express Apple Pay Google Pay PayPal
Ordering for a clinic, EMS, or facility? Use “Add to Quote” or contact us for tailored volume pricing.
Why EMRN?

Supplying clinics, EMS, long-term care and home-care across Canada with trusted equipment.

Product details

EMRN MEDICAL SUPPLIES · MedXL

CitraFlow™ 46.7% SF for Vascular Access Device locking

CitraFlow™ 46.7% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 46.7% trisodium citrate solution, specifically formulated for the locking and maintenance of vascular access devices such as

Product Information

CitraFlow™ 46.7% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 46.7% trisodium citrate solution, specifically formulated for the locking and maintenance of vascular access devices such as central venous catheters. This non-antibiotic, citrate-based lock solution provides effective antimicrobial and anticoagulant protection, helping to prevent catheter occlusion and reduce infection risk.

Manufactured under strict quality and sterility standards in Canada, CitraFlow™ 46.7% SF syringes are ready-to-use, eliminating the need for on-site compounding or dilution. Each syringe is precision-filled and designed with a smooth plunger action and leak-resistant barrel to ensure consistent, controlled delivery.
The 46.7% citrate concentration provides reliable catheter patency without the bleeding risks associated with heparin-based locks. CitraFlow™ SF is free of preservatives and latex, making it suitable for a wide range of patients, including those with heparin sensitivities or allergies.
Ideal for hospitals, dialysis centers, infusion clinics, and long-term care facilities, CitraFlow™ SF Prefilled Syringes support safe, efficient, and standardized vascular access maintenance protocols.
CitraFlow™ 46.7% SF prefilled syringes are filled with an anticoagulant and antimicrobial 46.7% sodium citrate solution. CitraFlow™ 46.7% SF is a proven alternative to heparin to lock Vascular Access Devices. It avoids the risks associated with systemic heparinization and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.

Models & Options

SKUConfiguration / contentsOrder
006-38143Size: 3ml 46.7% Sodium Citrate solution in 5ml syringe. 900/CaseAdd to Cart
006-38143‐1Size: twinpack of two 3ml 46.7% Sodium Citrate solution in 5ml syringe. 600/CaseAdd to Cart

FAQs

What is CitraFlow™ 46.7% SF for Vascular Access Device locking used for?

CitraFlow™ 46.7% SF Prefilled Syringes by MedXL are sterile, single-use syringes prefilled with 46.7% trisodium citrate solution, specifically formulated for the locking and maintenance of vascular access devices such as central venous catheters. This non-antibiotic, citrate-based lock solution provides effective antimicrobial and anticoagulant protection, helping to prevent catheter occlusion and reduce infection risk.

Which sizes or configurations can I order?

006-38143 — Size: 3ml 46.7% Sodium Citrate solution in 5ml syringe. 900/Case; 006-38143‐1 — Size: twinpack of two 3ml 46.7% Sodium Citrate solution in 5ml syringe. 600/Case.

Is this a saline flushing syringe or a catheter-lock solution?

CitraFlow is a vascular-access locking solution, not the same product as Praxiject 0.9% saline. Select the prescribed formulation and concentration according to institutional protocol and the product instructions.

Where are the official manufacturer instructions?

Open the MedXL product page or documentation index from the Documents & Resources tab, and verify the instructions for the exact reference number.